When assessing inflammation/aging and cell-type features for MDS SRSF2 mutant cases in both cohorts, we saw a statistically significant increase in GMP and GMP-like features (p<0.05), which are precursor cells to granulocytes and monocytes (Figure 6a–c). Here, SRSF2 is linked to myelodysplastic syndrome.